BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. ✅
Go to Publication ✅
International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 42 Issue 6 Pages: 475-81 Pub: 2013 Dec Epub: 2013 Sep 7 Authors Sikorska H , Smoragiewicz W , |
|
|
The Synergism of Human Lactobacillaceae and Inulin Decrease Hyperglycemia via Regulating the Composition of Gut Microbiota and Metabolic Profiles in db/db Mice. ✅
Go to Publication ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 33 Issue 12 Pages: 1-14 Pub: 2023 Aug 21 Epub: 2023 Aug 21 Authors Li P , Tong T , Wu Y , Zhou X , Zhang M , Liu J , She Y , Li Z , Li A , |
|
|
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. ✅
Go to Publication ✅
Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , |
|
|
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. ✅
Go to Publication ✅
Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , |
|
|
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. ✅
Go to Publication ✅
Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , |
|
|
Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 9 Pages: Pub: 2023 May 6 Epub: 2023 May 6 Authors Ozen M , Piloquet H , Schaubeck M , |
|
|
Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 9 Pages: Pub: 2023 May 6 Epub: 2023 May 6 Authors Ozen M , Piloquet H , Schaubeck M , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
A Mix of Potentially Probiotic Limosilactobacillus fermentum Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 4 Pages: Pub: 2024 Mar 26 Epub: 2024 Mar 26 Authors Carneiro Dos Santos LA , Carvalho RDO , Cruz Neto JPR , de Albuquerque Lemos DE , de Oliveira KÁR , Sampaio KB , de Luna Freire MO , Aburjaile FF , Azevedo VAC , de Souza EL , de Brito Alves JL , |
|
|
Harnessing the probiotic properties and immunomodulatory effects of fermented food-derived Limosilactobacillus fermentum strains: implications for environmental enteropathy. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1200926 Pub: 2023 Epub: 2023 Jun 5 Authors Prakash V , Madhavan A , Veedu AP , Babu P , Jothish A , Nair SS , Suhail A , Prabhakar M , Sain T , Rajan R , Somanathan P , Abhinand K , Nair BG , Pal S , |
|
|
Identification of Antimicrobial Peptides from Novel Lactobacillus fermentum Strain. ✅
Go to Publication ✅
The protein journal (Protein J ) Vol: 39 Issue 1 Pages: 73-84 Pub: 2020 Feb Epub: Authors Pavlova AS , Ozhegov GD , Arapidi GP , Butenko IO , Fomin ES , Alemasov NA , Afonnikov DA , Yarullina DR , Ivanov VT , Govorun VM , Kayumov AR , |
|
|
Administration of Lactobacillus fermentum KBL375 Causes Taxonomic and Functional Changes in Gut Microbiota Leading to Improvement of Atopic Dermatitis. ✅
Go to Publication ✅
Frontiers in molecular biosciences (Front Mol Biosci ) Vol: 6 Issue Pages: 92 Pub: 2019 Epub: 2019 Sep 27 Authors Kim WK , Jang YJ , Han DH , Seo B , Park S , Lee CH , Ko G , |
|
|
Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections. ✅
Go to Publication ✅
BMC microbiology (BMC Microbiol ) Vol: 14 Issue Pages: 107 Pub: 2014 Apr 27 Epub: 2014 Apr 27 Authors Alexandre Y , Le Berre R , Barbier G , Le Blay G , |
|
|
Lactobacillus fermentum 016 Alleviates Mice Colitis by Modulating Oxidative Stress, Gut Microbiota, and Microbial Metabolism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 3 Pages: Pub: 2025 Jan 26 Epub: 2025 Jan 26 Authors Pan H , Yang S , Kulyar MF , Ma H , Li K , Zhang L , Mo Q , Li J , |
|
|
Probiotic-Loaded Bacterial Cellulose as an Alternative to Combat Carbapenem-Resistant Bacterial Infections. ✅
Go to Publication ✅
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 13 Issue 11 Pages: Pub: 2024 Oct 25 Epub: 2024 Oct 25 Authors Gutiérrez-Fernández J , Cerezo-Collado L , Garcés V , Alarcón-Guijo P , Delgado-López JM , Dominguez-Vera JM , |
|
|
Probiotic-Loaded Bacterial Cellulose as an Alternative to Combat Carbapenem-Resistant Bacterial Infections. ✅
Go to Publication ✅
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 13 Issue 11 Pages: Pub: 2024 Oct 25 Epub: 2024 Oct 25 Authors Gutiérrez-Fernández J , Cerezo-Collado L , Garcés V , Alarcón-Guijo P , Delgado-López JM , Dominguez-Vera JM , |
|
|
A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome. ✅
Go to Publication ✅
NPJ science of food (NPJ Sci Food ) Vol: 8 Issue 1 Pages: 61 Pub: 2024 Sep 6 Epub: 2024 Sep 6 Authors Zhou T , Wu J , Khan A , Hu T , Wang Y , Salama ES , Su S , Han H , Jin W , Li X , |
|
|
Comparative Optimization of Culture Media for Enhanced ß-Glucan Production by Limosilactobacillus fermentumSH2 (MW897962) and Its Bioactivity Assessment. ✅
Go to Publication ✅
Food science & nutrition (Food Sci Nutr ) Vol: 13 Issue 9 Pages: e70960 Pub: 2025 Sep Epub: 2025 Sep 19 Authors Abedelmaksoud TG , Allaith SA , Altemimi AB , Abdel-Aziz ME , Thabit ZA , Hesarinejad MA , Mohamed RM , |
|
|
Limosilactobacillus fermentum IOB802 Protects Against Blue Light-Induced Retinopathy via Gut Microbiota Modulation. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 22 Pages: Pub: 2025 Nov 11 Epub: 2025 Nov 11 Authors Liu C , Zhao Y , Li J , Gao S , Cao J , Jing N , Han X , He H , Liang W , Wang N , |
|
|
Limosilactobacillus fermentum IOB802 Protects Against Blue Light-Induced Retinopathy via Gut Microbiota Modulation. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 22 Pages: Pub: 2025 Nov 11 Epub: 2025 Nov 11 Authors Liu C , Zhao Y , Li J , Gao S , Cao J , Jing N , Han X , He H , Liang W , Wang N , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
